Skip to main content
Mithra Pharmaceuticals S.A. logo

Mithra Pharmaceuticals S.A. — Investor Relations & Filings

Ticker · MITRA ISIN · BE0974283153 LEI · 5493002FDD273HTEKK14 BR Manufacturing
Open in API
Filings indexed 754 across all filing types
Latest filing 2023-11-07 Regulatory Filings
Country BE Belgium
Listing BR MITRA

About Mithra Pharmaceuticals S.A.

https://www.mithra.com/

Mithra Pharmaceuticals S.A. is a biotech company dedicated to women's health. The company focuses on the development, manufacturing, and commercialization of differentiated drugs and complex therapeutic solutions. Its core areas of expertise include contraception, fertility, and menopause. Mithra aims to transform the women's health sector by providing innovative choices to support and improve the overall quality of life for women.

Recent filings

Filing Released Lang Actions
2023-11-07_Mithra_Press-release_Mayne-Mithra-patent-extension-US_EN.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a specific corporate event: the granting of an additional patent for their product NEXTSTELLIS® in the United States, extending protection until 2036. This type of announcement, which details intellectual property protection, commercial agreements (Mayne Pharma license), and includes executive commentary, is typically classified as a general corporate update or news release. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a detailed management discussion (MDA). Since it is a specific announcement about a legal/IP development that doesn't fit the other specific categories (like DIRS, DIV, CAP, or TAR), the most appropriate classification is the general Regulatory Filings/News category (RNS), as it serves as a broad announcement of material information.
2023-11-07 English
2023-11-07_Mithra_Press-release_Mayne-Mithra-patent-extension-US_FR.pdf
Legal Proceedings Report Classification · 99% confidence The document is a press release dated November 7, 2023, announcing that Mithra has obtained a new patent for its product NEXTSTELLIS® in the United States, extending protection until 2036. The content focuses on a specific legal/intellectual property event (patent grant) and its commercial implications, rather than routine financial reporting (like 10-K, ER, IR) or management changes (MANG). This type of announcement, detailing a legal protection update, fits best under 'Legal Proceedings Report' (LTR) as it concerns intellectual property rights and litigation defense, or potentially 'Regulatory Filings' (RNS) as a general announcement. Given the focus on a patent grant and its impact on market exclusivity, LTR is a strong candidate, but since it is a positive announcement about IP protection rather than a report on ongoing litigation or regulatory action against the company, and it is a specific corporate update, it is often categorized as a general regulatory/corporate announcement. However, among the specific codes, 'LTR' covers legal matters. If LTR is interpreted strictly as adverse legal proceedings, then 'RNS' (Regulatory Filings/Miscellaneous Announcement) is the fallback. Since the core subject is a patent grant, which is a form of regulatory/legal protection, and it doesn't fit perfectly into the other specific categories like ER, IR, or CAP, I will classify it as a general corporate announcement that doesn't fit elsewhere, leaning towards RNS, or potentially IP if that were an option. Since IP is not an option, and it is not a financing event (CAP), I will use RNS as the most appropriate general regulatory announcement category for a patent update that is not a financial report.
2023-11-07 French
2023-11-06_MITHRA_EGM-NOVEMBER-2023_PROXY_EN.pdf
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a proxy form for an Extraordinary General Meeting (EGM) of Mithra Pharmaceuticals SA. It contains the agenda, proposed resolutions regarding capital increases, and instructions for shareholders to appoint a proxy holder to vote on their behalf. This falls under the category of materials sent to shareholders to provide information and request votes for meetings.
2023-11-06 English
2023-11-06_MITHRA_EGM-NOVEMBER-2023_PROXY_FR.pdf
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Procuration' (Proxy) form for an Extraordinary General Meeting (EGM) of Mithra Pharmaceuticals SA. It includes the agenda, proposed resolutions for capital increases, and voting instructions for shareholders. This type of document is sent to shareholders to provide information and request their votes for a meeting, which fits the definition of a Proxy Solicitation & Information Statement.
2023-11-06 French
Board Report - Subscription rights issuance (ENG).pdf
Capital/Financing Update Classification · 98% confidence The document is a formal 'Report of the Board of Directors' prepared in accordance with specific articles of the Belgian Companies and Associations Code. It details a capital increase, the issuance of warrants and investment options, and the cancellation of preferential subscription rights in favor of an investor (Armistice Capital). This is a detailed corporate governance and capital structure document explaining management's rationale for a specific transaction, which falls under the category of management reports regarding financial and capital structure decisions.
2023-11-06 English
Board Report - Subscription rights issuance (FR) - Executed.pdf
Capital/Financing Update Classification · 98% confidence The document is a formal 'Rapport du Conseil d'Administration' (Board of Directors' Report) prepared in accordance with specific articles of the Belgian Code of Companies and Associations (7:180, 7:191, 7:193). It details a private placement of shares, the issuance of warrants and investment options, and the modification of financing agreements. This document is a management report explaining the rationale, financial impact, and legal justification for corporate actions to be voted on at an upcoming Extraordinary General Meeting (AGE). It fits the definition of a management report detailing business trends and outlook, specifically regarding capital structure changes.
2023-11-06 French

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.